Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Connect Biopharma Holdings Ltd ADR
(NQ:
CNTB
)
1.022
+0.012 (+1.20%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Connect Biopharma Holdings Ltd ADR
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 29, 2023
Via
Benzinga
Week in Review: SystImmune Out-Licenses Global Rights for ADC to BMS in $8.4 Billion Deal
December 16, 2023
SystImmune, the Seattle arm of Chengdu’s Biokin Pharma, out-licensed global rights (ex-China) for a bispecific ADC to Bristol Myers Squibb in a $8.4 billion agreement.
Via
Talk Markets
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 12, 2023
Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 12, 2023
Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
December 11, 2023
Via
Benzinga
Week In Review: BeiGene Signs $1.3 Billion Deal For Preclinical CDK2 Inhibitor From Boston’s Ensem
November 25, 2023
Beijing’s BeiGene acquired global rights to a preclinical novel cyclin-dependent kinase 2 (CDK2) inhibitor from Boston’s Ensem Therapeutics in a $1.3 billion agreement. Ensem will receive an upfront...
Via
Talk Markets
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 22, 2023
Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.
Via
Benzinga
Why Guess? Shares Are Trading Lower By Around 15%; Here Are 20 Stocks Moving Premarket
November 22, 2023
Shares of Guess?, Inc. (NYSE: GES) shares dipped in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued fourth-quarter adjusted EPS guidance...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 22, 2023
Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning!
Via
InvestorPlace
Why Is Skin Disease-Focused Connect Biopharma Stock Lower Today?
November 21, 2023
Connect Biopharma Holdings Limited (NASDAQ: CNTB) released topline results from Stage 2 (maintenance period) of its China pivotal trial evaluating rademikibart's (formerly known as CBP-201) efficacy...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 21, 2023
Via
Benzinga
Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
November 21, 2023
Shares of Symbotic Inc. (NASDAQ: SYM) surged in pre-market trading after the company reported better-than-expected fourth-quarter sales results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 21, 2023
It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
November 17, 2023
Via
Benzinga
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
October 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 22, 2023
Via
Benzinga
Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 05, 2023
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 12, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 05, 2023
It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Week In Review: Betta Pharma Enters $392 Million Deal For C4 Therapeutics’ NSCLC Drug
June 03, 2023
Hangzhou Betta Pharma acquired greater China rights for a novel non-small cell lung cancer drug from Boston’s C4 Therapeutics in a deal worth up to $392 million. Additionally, Lynk Pharma of Hangzhou...
Via
Talk Markets
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.